Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: Clinical relevance in 71 patients
نویسندگان
چکیده
منابع مشابه
Large B - Cell Lymphoma Clinical Relevance of BCL 2 , BCL 6 , and MYC Rearrangements in Diffuse
http://bloodjournal.hematologylibrary.org/content/92/9/3152.full.html Updated information and services can be found at: (3667 articles) Clinical Trials and Observations Articles on similar topics can be found in the following Blood collections http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#repub_requests Information about reproducing this article in parts or in its entirety...
متن کاملClinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma.
Diffuse large B-cell lymphoma (DLCL) is characterized by a marked degree of morphologic and clinical heterogeneity. We studied 156 patients with de novo DLCL for rearrangements of the BCL2, BCL6, and MYC oncogenes by Southern blot analysis and BCL2 protein expression. We related these data to the primary site of presentation, disease stage, and other clinical risk factors. Structural alteration...
متن کاملThe prognostic role of Bcl-2, Ki67, c-MYC and p53 in diffuse large B-cell lymphoma.
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of lymphoid malignancies, which counts for more than a third of non-Hodgkin's lymphoma cases. The aim of the current study is to evaluate the prognostic role of several immunohistochemical (IHC) markers involved in the pathological process of DLBCL. This is a retrospective analysis of the 97 de novo DLBCL patients admitted between J...
متن کاملBcl-2 protein frequency in patients with high-risk diffuse large B-cell lymphoma.
CONTEXT AND OBJECTIVE Gene expression and immunohistochemical profiling of diffuse large B-cell lymphoma (DLBCL) have revealed important prognostic subgroups: germinal center B-cell-like (GCB-like) DLBCL and activated B cell-like (ABC-like) DLBCL. Although few reports on high-risk DLBCL are available, the prognosis for the GCB-like subgroup has been shown to be better than that of the ABC-like ...
متن کاملBCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?
BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we? We read with interest the paper by Winter et al 1 in which they report the impact of BCL-6 protein expression on outcome in diffuse large B-cell lymphoma (DLBCL) patients treated with cyclophospha-mide, doxorubicin, vincristine, and prednisone (CHOP) with rituximab (R-CHOP) or without. These findings provide potentially importa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 1998
ISSN: 0923-7534
DOI: 10.1023/a:1008201729596